Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
LMNL similar filings
Filing view
External links
Consent of Independent Auditors
We consent to the incorporation by reference in the Registration Statements (Form S-8 no. 333-235692) pertaining to the Omnibus Incentive Plan, amended and Restated Stock Option Plan, and Restricted Share Unit Plan of Liminal BioSciences Inc. of our report dated March 27, 2018, with respect to the consolidated statements of operations, comprehensive loss, changes in equity and cash flows for the year ended December 31, 2017 included in the Annual Report on Form 20-F for the year ended December 31, 2019.
/s/ Ernst & Young LLP1
Montreal, Canada
March 20, 2020
__________________________________________
(1) CPA Auditor, CA, public accounting permit no. A123806